IT · Gartner, Inc. · Stock research

Current Thesis

The leg being bought is a de-rating reversal in a franchise the market had marked down as AI roadkill — and since the 2026-08-09 note that leg has kept working on price while producing no new fundamental information. The 2026-08-21 reference close of $195.9 is 25.8% under the 52-week high of $264.09, up 22.4% over three months, with RSI(14) at 76.7. Everything that re-rated the stock arrived in a single session: the 2026-08-04 Q2 print (adjusted EPS $4.37 against $3.75 consensus, revenue $1.676B against $1.650B), a raised FY26 adjusted EPS guide of ≥$14.00 from ≥$13.25, and a 23.7% one-day move.

What has happened since is thinner and worth naming precisely. On 2026-08-18 BMO Capital maintained Market Perform and lowered its target to $206 from $214 — the one published mark still above the current quote moved down, not up. No covering firm has moved to Buy. And there is no scheduled company disclosure between now and the Q3 report, which MarketBeat estimates at 2026-11-03 from prior-year dates.

So the character of the position has changed even though the fundamentals have not: an investor entering here is paying roughly 5.5% more than at the 2026-08-09 note for exactly the same evidence set, into an overbought reading, with roughly ten weeks of nothing scheduled. The narrative is maturing — still working, well understood, with flow moderating: coverage clustered on 2026-08-04/05 (four target raises in one day), thinned to a single action by 2026-08-18, and that action was a cut.

Bullish and bearish views on Gartner, Inc.

The model's bull view on Gartner, Inc. (IT), in brief: Q2 2026 (2026-08-04): adjusted EPS $4.37 vs $3.75 estimate; revenue $1.676B vs $1.650B, +3% YoY; adjusted EBITDA $466M, +6.4% YoY, 27.8% margin. The bear view: The revenue guide went down while EPS went up. Both cases follow in full.

Bull Case

• Q2 2026 (2026-08-04): adjusted EPS $4.37 vs $3.75 estimate; revenue $1.676B vs $1.650B, +3% YoY; adjusted EBITDA $466M, +6.4% YoY, 27.8% margin.
• Contract value stopped deteriorating: $5.28B at 2026-06-30, +1.7% YoY as reported, ex-federal +3.3%, total CV growth 70bps better than Q1 2026. GTS CV +1% YoY, GBS CV +3% YoY.
• Guidance raised on three of four lines on 2026-08-04: adjusted EPS ≥$14.00 (from ≥$13.25), adjusted EBITDA ≥$1.57B (from ≥$1.55B), free cash flow ≥$1.19B (from ≥$1.16B). GAAP EPS guided above $13.14 against a $12.86 estimate.
• The company is the marginal buyer: 3.6M shares retired for $547M in Q2 2026, $1.2B remaining on the authorization, and an incremental $500M authorized on 2026-07-30 — announced five days before the gap, so a portion of any Q3 repurchase lands above $185. Balance sheet at 2026-06-30: $1.49B cash, $3.0B debt, 0.9x net leverage.
• Conferences $244M, +15.5% YoY (+14.2% FX-neutral), contribution margin 59.5%, up 210bps. Inferred read: in-person peer benchmarking retains pricing power while document-based research growth stalls, which the blanket AI-substitution case does not separate out.
• BMO's $206 mark (2026-08-18) remains above the 2026-08-21 close, so the stock is not yet through every published target.

Bear Case

• The revenue guide went down while EPS went up. FY26 revenue ≥$6.375B against a $6.431B consensus, trimmed from ≥$6.41B. Margin and share count carried the raise; demand did not improve.
• +1.7% CV growth on the book is close to flat. Cost-out and buyback are finite mechanisms.
• Consulting is contracting: $142M in Q2 2026, -8.8% YoY, contribution margin off 170bps.
• The only post-print sell-side action was a target cut (BMO $214 → $206, 2026-08-18), against four raises on 2026-08-05 that all still carried Neutral, Sector Perform or Underweight ratings.
• Insiders sold into the gap. Three Form 4 dispositions between 2026-08-07 and 2026-08-10, at $184.30, $190.71 and $190.06. Small in share count against a multi-billion float; directionally one-way.
• One quarter does not resolve AI substitution. Nothing disclosed on 2026-08-04 measures renewal behaviour at enterprises running internal LLMs against the questions syndicated research answers. The next dated read is the Q3 print.

Setup & Price Structure

• Reference close 2026-08-21: $195.9. Three-month price change +22.4%; 25.8% below the $264.09 52-week high. RSI(14) at 76.7 — an overbought reading, measured, with the caveat that momentum names hold RSI above 70 for extended stretches and the indicator alone dates nothing.
• The 2026-08-04 gap has not been filled or faded. Shares closed $185.6 on 2026-08-07 and $195.9 on 2026-08-21: the post-print shelf has been extended, not surrendered, which is the structural argument for the leg still being intact.
• Overhead published marks: UBS $196 (2026-08-05), BMO $206 (2026-08-18). Beneath the quote sit Goldman $181, Morgan Stanley $173 (2026-07-10), RBC $164 and Wells Fargo $150. Price now clears four of six and is within a dollar of the fifth.
• Crowding and positioning observables, stated without a verdict: RSI 76.7 into a no-catalyst window; three insider open-market sales in the four sessions after the print; zero Buy ratings among six named firms; no imminent earnings date to force resolution; no equity issuance — the company retired 3.6M shares in Q2 and added authorization on 2026-07-30. The vectors point in opposite directions, which is why this is a positioning description rather than a conclusion.
• The narrative is maturing. Dated by the collapse in coverage cadence between 2026-08-05 (four actions in one day) and 2026-08-18 (one action, a reduction), against a price that kept grinding.

Catalyst Calendar (next 30 days)

• 2026-08-22 → 2026-09-21: no dated company disclosure. This is the material fact about the window. Section 16 filings are event-driven and not calendared; there is no scheduled print, guide update or investor day in the period.
• 2026-09-30 — Q3 2026 contract-value measurement date. CV is a period-end figure; the number that decides the thesis is fixed on this date and disclosed roughly five weeks later.
• ~2026-10 (est.) — Gartner IT Symposium/Xpo, Orlando. Largest annual conference; the live demand read on the segment that grew 15.5% YoY in Q2 2026.
• ~2026-11-03 (est.) — Q3 2026 results. MarketBeat estimates the date from prior-year reporting; the company has not confirmed it.

What Would Change Our Mind

The structure at risk is the shelf built between the 2026-08-04 gap and the 2026-08-21 close, and it would have to give way with no company data in the interval to break the thesis — a drift-down on flow alone through an empty ten-week calendar. A weekly close below $168 marks that gap as failed and returns the stock to its pre-print range without a fundamental trigger. Ahead of that, losing the $181–$185 band where the stock consolidated in the first week after the print would signal the post-gap bid thinning.

On fundamentals, the thesis breaks if total contract-value growth at the Q3 print comes in at or below the +1.7% YoY posted at 2026-06-30 — the entire re-rating rests on the 70bps of sequential improvement continuing — or if FY26 revenue guidance is trimmed a second time below ≥$6.375B. It also weakens quietly if the print arrives and adjusted operating margin is flat to down YoY against the 25% posted in Q2 2026, since that would identify the EPS beat as a one-quarter cost event.

What would strengthen it: a first Buy rating from any of the six covering firms currently at Neutral or below, or Q3 disclosure showing the buyback deployed materially above $185.

Correlation Notes

• Not an AI-capex beneficiary. Gartner trades on the AI-substitution debate, so it can fall on days when semiconductor and memory names rally — a different axis from the 2026-08-06 cheap-memory story (SanDisk, Micron) that dominated the same news window.
• Federal-spending complex. The gap between ex-federal CV growth (+3.3%) and total (+1.7%) at 2026-06-30 makes the name partly a read on US government contracting, alongside government-services and consulting exposures.
• Conferences ties to business-travel and event demand, which moves with corporate discretionary budgets rather than with software spending.
• Tape context: the 2026-08-04 session was a broad record-high day for the S&P 500 with Palantir +27%. The 23.7% single-name move was company-specific, but the follow-through since has come without an obvious sector sponsor.